All companies › EW

EW · Edwards Lifesciences Corp

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells7
Research cases0
Last filing2026-10-08

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-26 — Markowitz Wayne · sold 1,240 @ $91.47 2026-08-26 — Chopra Daveen · sold 1,154 @ $91.76 2026-08-26 — Chopra Daveen · sold 30,646 @ $90.99 2026-08-28 — Bruls Annette · sold 2,644 @ $89.98 2026-08-31 — Dahl Andrew M. · sold 544 @ $91.06 2026-09-11 — Lippis Daniel J. · sold 619 @ $87.51 2026-10-08 — Lippis Daniel J. · sold 619 @ $85.65
2026-08-262026-10-08

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Chopra Daveen CVP, TMTT, Surgical & IHFM
Lippis Daniel J. CVP, TAVR
Markowitz Wayne CVP, JAPAC
Bruls Annette CVP, EMEACLA
Dahl Andrew M. SVP, Corporate Controller
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $EW is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-08', 'insider_name': 'Lippis Daniel J.', 'insider_title': 'CVP, TAVR', 'transaction_type': 'Open-market sell', 'shares': 619.0, 'price': 85.65, 'value': 53017.35, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Lippis Daniel J.', 'insider_title': 'CVP, TAVR', 'transaction_type': 'Open-market sell', 'shares': 619.0, 'price': 87.51, 'value': 54168.69, 'is_buy': False}, {'transaction_date': '2026-08-31', 'insider_name': 'Dahl Andrew M.', 'insider_title': 'SVP, Corporate Controller', 'transaction_type': 'Open-market sell', 'shares': 544.0, 'price': 91.06, 'value': 49536.64, 'is_buy': False}, {'transaction_date': '2026-08-28', 'insider_name': 'Bruls Annette', 'insider_title': 'CVP, EMEACLA', 'transaction_type': 'Open-market sell', 'shares': 2644.0, 'price': 89.98, 'value': 237907.12, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Markowitz Wayne', 'insider_title': 'CVP, JAPAC', 'transaction_type': 'Open-market sell', 'shares': 1240.0, 'price': 91.47, 'value': 113422.8, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Chopra Daveen', 'insider_title': 'CVP, TMTT, Surgical & IHFM', 'transaction_type': 'Open-market sell', 'shares': 1154.0, 'price': 91.76, 'value': 105891.04, 'is_buy': False}, {'transaction_date': '2026-08-26', 'insider_name': 'Chopra Daveen', 'insider_title': 'CVP, TMTT, Surgical & IHFM', 'transaction_type': 'Open-market sell', 'shares': 30646.0, 'price': 90.99, 'value': 2788479.54, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for EW today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.